Universal Health Services, Inc. vs Mouwasat Medical Services Co.
A head-to-head of Universal Health Services, Inc. (UHS) and Mouwasat Medical Services Co. (4002) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | UHS | 4002 |
|---|---|---|
| Market Cap | $9.15B | 12.18B SAR |
| P/E (TTM) | 6.54 | 14.82 |
| Forward P/E | 6.72 | 13.87 |
| P/S | 0.58 | 4.02 |
| P/B | 1.25 | 3.06 |
| EV/EBITDA | 5.76 | 12.54 |
| Dividend Yield | 0.54% | 6.24% |
| Profit Margin | 8.56% | 25.09% |
| Gross Margin | 90.45% | 42.25% |
| Operating Margin | 11.48% | 26.98% |
| Revenue Growth (YoY) | +9.65% | +9.09% |
| FCF Yield | 7.98% | 5.10% |
| Debt / Equity | 64.18 | 28.00 |
| Current Ratio | 1.08 | 1.62 |
Which is better: Universal Health Services, Inc. or Mouwasat Medical Services Co.?
- ✓Larger by market cap: Mouwasat Medical Services Co.
- ✓Cheaper valuation (lower P/E): Universal Health Services, Inc.
- ✓Higher dividend yield: Mouwasat Medical Services Co.
- ✓More profitable (net margin): Mouwasat Medical Services Co.
- ✓Faster revenue growth: Universal Health Services, Inc.
- ✓Higher free-cash-flow yield: Universal Health Services, Inc.
Across 13 available metrics, Universal Health Services, Inc. leads 8–5.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.